Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.56 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.56 |
| ▸ | CA12 | O43570 | 5/20 | 0.55 |
| ▸ | CA1 | P00915 | 5/20 | 0.55 |
| ▸ | CA2 | P00918 | 5/20 | 0.55 |
| ▸ | CA7 | P43166 | 5/20 | 0.55 |
| ▸ | CA9 | Q16790 | 5/20 | 0.55 |
| ▸ | CA14 | Q9ULX7 | 5/20 | 0.55 |
| ▸ | CA4 | P22748 | 4/20 | 0.52 |
| ▸ | CA6 | P23280 | 4/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.52 |
| ▸ | MAPT | P10636 | 3/20 | 0.52 |
| ▸ | CA3 | P07451 | 3/20 | 0.52 |
| ▸ | CA5A | P35218 | 3/20 | 0.52 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | TP53 | P04637 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | SELL | P14151 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Citrazinic Acid SCHEMBL28292100 | 0.97 | TSHR (0.54) | TSHRALOX15HIF1ACA12CA1 | |
| Citrazinic Acid SCHEMBL10818912 | 0.97 | TSHR (0.54) | TSHRALOX15HIF1ACA12CA1 | |
| Citrazinic Acid SCHEMBL11217659 | 0.97 | TSHR (0.54) | TSHRALOX15HIF1ACA12CA1 | |
| Citrazinic Acid SCHEMBL27862917 | 0.91 | ALOX15 (0.48) | TSHRALOX15HIF1ACA12CA1 | |
| SCHEMBL3125361 | 0.85 | ALOX15 (0.74) | TSHRALOX15HIF1ACA12CA1 | |
| SCHEMBL2085141 | 0.84 | TPMT (0.48) | TSHRALOX15HIF1ACA12CA1 | |
| SCHEMBL6844134 | 0.84 | GABRP (0.48) | TSHRALOX15HIF1ACA12CA1 | |
| SCHEMBL6160746 | 0.84 | TTR (0.50) | TSHRALOX15HIF1ACA12CA1 | |
| SCHEMBL3558227 | 0.79 | DAO (0.43) | TSHRALOX15HIF1ACA12CA1 | |
| SCHEMBL7675313 | 0.77 | CTRC (0.63) | KDM4EALDH1A1TP53LMNAHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1698 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122079136-A | Carbon dot, preparation method and application thereof, and antitumor drug | — | 2026-05-26 | — | — | CN | claimed |
| CN-115923272-B | Low-energy-consumption conveyer belt | 青岛环球输送带有限公司 | 2025-06-24 | — | — | CN | claimed |
| CN-120025557-A | Hafnium-based coordination polymer catalyst, preparation method thereof and application thereof in preparation of vanillyl alcohol ether | 淮阴师范学院 | 2025-05-23 | — | — | CN | claimed |
| CN-119016719-A | Citrazinic acid functionalized silver nanoparticle and preparation method and application thereof | 深圳大学 | 2024-11-26 | — | — | CN | claimed |
| US-12077680-B2 | Polishing composition, production method of the same, polishing method and a manufacturing method of a semiconductor substrate | FUJIMI INCORPORATED (JP) | 2024-09-03 | — | — | US | claimed |
| US-12076316-B2 | Levorphanol prodrugs and processes for making and using them | ZEVRA THERAPEUTICS INC. | 2024-09-03 | — | — | US | claimed |
| WO-2024139384-A1 | DRUG BALLOON DILATATION CATHETER FOR NON-VASCULAR INTERVENTION | 微创优通医疗科技（上海）有限公司 | 2024-07-04 | — | — | WO | claimed |
| WO-2024139383-A1 | PREPARATION METHOD FOR COATING SOLUTION, AND DRUG BALLOON FOR NON-VASCULAR INTERVENTION AND PREPARATION METHOD THEREFOR | 微创优通医疗科技（上海）有限公司 | 2024-07-04 | — | — | WO | claimed |
| CN-118267594-A | A medicine sacculus inflation pipe for non-vascular intervention | 微创优通医疗科技（上海）有限公司 | 2024-07-02 | — | — | CN | claimed |
| CN-116712615-B | Preparation method of coating solution, medicine balloon for non-vascular intervention and preparation method | 微创优通医疗科技（上海）有限公司 | 2024-05-24 | — | — | CN | claimed |
| EP-0527186-A4 | — | UNIV ILLINOIS (US) | 1995-01-18 | — | — | EP | claimed |
| US-5382481-A | Battery has anode with donor aromatic compound, cathode with acceptor compound, and electrolyte; reversible; electronics | E.C.R.-ELECTRO-CHEMICAL RESEARCH LTD. (IL) | 1995-01-17 | — | — | US | claimed |
| EP-0364845-B1 | Photographic-reversal process | AGFA GEVAERT AG (DE) | 1995-01-04 | — | — | EP | claimed |
| EP-0300461-B1 | Aromatic heterocyclic peroxyacids | AUSIMONT SPA (IT) | 1994-01-12 | — | — | EP | claimed |
| EP-0527186-A1 | PHOTODYNAMIC PLANT DEFOLIANTS AND CHLOROPHYLL BIOSYNTHESIS MODULATORS | The Board of Trustees for the University of Illinois (US) | 1993-02-17 | — | — | EP | claimed |
| US-5110715-A | Black and white development followed by color development with no washing step required between them | AGFA GAVAERT AKTIENGESELLSCHAFT (DE) | 1992-05-05 | — | — | US | claimed |
| WO-1991016820-A1 | PHOTODYNAMIC PLANT DEFOLIANTS AND CHLOROPHYLL BIOSYNTHESIS MODULATORS | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 1991-11-14 | — | — | WO | claimed |
| US-4221860-A | COLOR REVERSAL, DEVELOPMENT WITH COMPETING COUPLER, EMULSION CONTAINING BLUE-SENSITIVE METHYLENE COUPLER | FUJI PHOTO FILM CO., LTD. (JP) | 1980-09-09 | — | — | US | claimed |
| US-4194911-A | COLOR ACCELERATOR, CONTRAST CONTROL AGENT BUFFER | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1980-03-25 | — | — | US | claimed |
| US-4161406-A | COLOR REVERSAL CINE FILM, DEVELOPMENT BATH CONTAINING MORE COMPETING COUPLER AND SILVER HALIDE SOLVENT AND LESS REVERSAL AGENT | PHILIP A. HUNT CHEMICAL CORP. (US) | 1979-07-17 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12076316-B2 | Levorphanol prodrugs and processes for making and using them | OPRM1, OPRL1, OPRK1 | TSHR 359/4885ALOX15 570/4885HIF1A 2461/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.